Cardiology
RSSArticles
-
Clinical Briefs
In this section: treating depression; the subdural risk of antithrombotics; and the health consequences of a poor diet.
-
Ocrelizumab Injection (Ocrevus)
Ocrelizumab is indicated for the treatment of patients suffering from relapsing multiple sclerosis or primary progressive multiple sclerosis.
-
A New Risk Score for Stroke in Atrial Fibrillation
A new, simpler score for stroke risk prediction in atrial fibrillation patients uses biomarkers to supplant many clinical variables and outperforms the CHA2DS2-VASc score in two large cohorts.
-
Treating Erectile Dysfunction After Myocardial Infarction May Be Safe
In a Swedish nationwide cohort study of men < 80 years of age hospitalized for myocardial infarction, treatment for erectile dysfunction with phosphodiesterase-5 inhibitors resulted in lower mortality and heart failure hospitalization.
-
Considering More Intensive Blood Pressure Control in the Elderly
In elderly, hypertensive patients, intensive blood pressure (BP) control (systolic BP < 140 mmHg) decreased major adverse cardiovascular events, including cardiovascular mortality and heart failure.
-
Beetroot Juice and Aerobic Endurance and Blood Pressure
Researchers found that drinking beetroot juice daily improves submaximal aerobic endurance in patients with cardiac failure and preserved ejection fraction.
-
Low Back Pain: Evidence for Nonpharmacologic Therapies
Developed for use in the new American College of Physicians guidelines, the authors reviewed evidence regarding non-pharmacologic interventions in treatment of low back pain.
-
Insomnia Disorder: Evidence for Psychological and Behavioral Interventions
Cognitive behavioral therapy for insomnia (CBT-I) is an effective intervention for moderate to severe insomnia disorder and should be considered as an initial treatment.
-
Tai Chi for Knee Osteoarthritis
Tai chi is as effective as a standard course of physical therapy in the treatment of pain of osteoarthritis of the knee.
-
Study Challenges Orthodoxy of IV Hydration for Prevention of Contrast Nephropathy
SYNOPSIS: This trial randomized 660 patients with chronic kidney disease and a planned procedure requiring intravascular iodinated contrast to prophylactic hydration or to no hydration. No hydration was found to be non-inferior for prevention of contrast-induced nephropathy and saved significant costs.